Across TCGA patient cohorts, MYCBP mutation is significantly associated with the immune_cell of many other genes, with 2 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible MYCBP-associated genes across cancer lineages are Eosinophils and lymphatic Endothelial cells. Each is linked with MYCBP in more than 1 cancer types. Because this analysis shows association rather than direction, both MYCBP-to-partner and partner-to-MYCBP results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (MYCBP→partner) and Y-score (partner→MYCBP) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
UCEC	Eosinophils →	-0.069	-2.967	.029	.037	3	1
UCEC	lymphatic Endothelial cells →	-0.028	-2.946	.043	.037	1	1

Each partner links to its Q-omics profile. Showing the 2 strongest of 2 associations by consensus.

Exploration

MYCBP survival (RNA) · tumor vs normal (RNA) · all MYCBP data types